Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Germany’s Merck triumphs in court battle with US namesake

English court rules Merck & Co breached the firms' naming agreement

EISAI

Eisai’s Lenvima gets FDA priority review for kidney cancer

The oncology treatment could now be approved in the US before the summer

- PMLiVE

David Kendall joins Alimentary Health

He will take up to role of business development director UK

Lucid’s digital responsibility: delivering value by improving patient outcomes

Digital initiatives must address your customer's needs

Lucid Group Communications Limited

Weber Shandwick acquires US healthcare communications firm

Strikes deal with ReviveHealth in bid to boost its integrated health comms services

Why are we still talking about multichannel?

Interview with Sebastian Kölsch, Chief Solutions Officer at Anthill.

Anthill Agency

EU flag

Biogen-Samsung’s Enbrel biosimilar cleared for EU marketing

The companies plan to launch the treatment in the coming weeks

- PMLiVE

GalbraithWight appoints Eithne McShane and Steve Mazzarese

They join the market access consultancy as global business development directors

- PMLiVE

Research Partnership appoints graphic designer to head office team

Amanda Brent will create 'storytelling solutions' for the agency

- PMLiVE

French government begins investigation into fatal Biotrial study

First-in-man trial leaves one dead, five hospitalised

- PMLiVE

Graham Belgrave joins Cmed Clinical Sciences

He will take up the role of chief operations officer

Brain cancer glioblastoma

Glioblastoma market set for ‘meteoric rise’

Sales of treatments for rare brain cancer predicted to reach $3.3bn by 2024

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links